# Evaluation of Two Doses of Nitric Oxide (NO) Given Intermittently Via Inhalation to Subjects With Bronchiolitis

> **NCT04060979** · PHASE2 · COMPLETED · sponsor: **Beyond Air Inc.** · enrollment: 95 (actual)

## Conditions studied

- Bronchiolitis Acute

## Interventions

- **DRUG:** Nitric Oxide
- **OTHER:** Standard Supportive treatment

## Key facts

- **NCT ID:** NCT04060979
- **Lead sponsor:** Beyond Air Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-06
- **Primary completion:** 2020-03-02
- **Final completion:** 2020-04-02
- **Target enrollment:** 95 (ACTUAL)
- **Last updated:** 2020-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04060979

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04060979, "Evaluation of Two Doses of Nitric Oxide (NO) Given Intermittently Via Inhalation to Subjects With Bronchiolitis". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT04060979. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*